Health & Biotech
Check up: COVID-19 is back in fashion
Respiri patient trial, bottom line both on track
The health stocks still taking a hit from COVID-19
Imagion tech brings down Tesla
US FDA approval is on the agenda for these 5 ASX small caps
Respiri links up with BNPL rocket Zip Co
Immuron’s diarrhoea drug may help treat COVID-19; investors get excited
CannPal’s doggie drug DermaCann tackles atopic dermatitis
Mandatory masks in Melbourne ignite these ASX small caps
Micro-X’s Rover gets the green light from the FDA
MGC Pharma expands footprint with cannabis clinic acquisition
Is Compass Cannabis your next ASX pot stock?
Dr Boreham’s Crucible: Hydrix who?
Respiri’s biggest deal yet gives it access to the world
Incannex Healthcare’s cannabidiol treatment for respiratory disease looks promising, shares climb
Health Kick: Pancreatic cancer treater OncoSil continues impressive bounce-back
Another two ASX stocks enter the race for faster COVID-19 tests
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
